{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:16:20Z","timestamp":1788264980663,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ymthe.2026.08.025","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T23:25:33Z","timestamp":1787181933000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice"],"prefix":"10.1016","author":[{"given":"Junqi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingling","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuncheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaokai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-6315","authenticated-orcid":false,"given":"Yushun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.08.025_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s40121-024-01012-2","article-title":"Differences Between RSV A and RSV B Subgroups and Implications for Pharmaceutical Preventive Measures","volume":"13","author":"Nuttens","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01432-25","article-title":"High seroprevalence and high risk: why are older adults more prone to respiratory syncytial virus?","volume":"99","author":"Rzymski","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14113880","article-title":"Respiratory Syncytial Virus: A Narrative Review of Updates and Recent Advances in Epidemiology, Pathogenesis, Diagnosis, Management and Prevention","volume":"14","author":"Asseri","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ymthe.2026.08.025_bib4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.immuni.2019.08.007","article-title":"Immunological Lessons from Respiratory Syncytial Virus Vaccine Development","volume":"51","author":"Ruckwardt","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.025_bib5","article-title":"Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines","volume":"12","author":"Topalidou","year":"2023","journal-title":"Pathogens (Basel, Switzerland)"},{"key":"10.1016\/j.ymthe.2026.08.025_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms12112305","article-title":"Immune Responses to Respiratory Syncytial Virus Vaccines: Advances and Challenges","volume":"12","author":"Silva","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/j.ymthe.2026.08.025_bib7","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2368288","article-title":"Induction of protective immune responses at respiratory mucosal sites","volume":"20","author":"Park","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.08.025_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s43556-025-00301-7","article-title":"Mucosal immunity and vaccination strategies: current insights and future perspectives","volume":"6","author":"Zhang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.ymthe.2026.08.025_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ymthe.2025.10.038","article-title":"CircRNA: Unlocking new frontiers in therapeutic and vaccine development","volume":"34","author":"Bahrulolum","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26010379","article-title":"Expanding the Potential of Circular RNA (CircRNA) Vaccines: A Promising Therapeutic Approach","volume":"26","author":"Bu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.08.025_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/v17050691","article-title":"Receptor Binding for the Entry Mechanisms of SARS-CoV-2: Insights from the Original Strain and Emerging Variants","volume":"17","author":"Mahdi","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.08.025_bib12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ame2.70018","article-title":"Respiratory virus mRNA vaccines: mRNA Design, clinical studies, and future challenges","volume":"8","author":"Zheng","year":"2025","journal-title":"Anim. Model. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.08.025_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13030304","article-title":"Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods","volume":"13","author":"Deng","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.08.025_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26115138","article-title":"A Complete Approach for circRNA Therapeutics from Purification to Lyophilized Delivery Using Novel Ionizable Lipids","volume":"26","author":"Broset","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2026.08.025_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.720","article-title":"Synthetic circRNA therapeutics: innovations, strategies, and future horizons","volume":"5","author":"Cai","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ymthe.2026.08.025_bib16","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1021\/nn4057269","article-title":"Cell-penetrating peptides: design, synthesis, and applications","volume":"8","author":"Copolovici","year":"2014","journal-title":"ACS nano"},{"key":"10.1016\/j.ymthe.2026.08.025_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pharmthera.2015.07.003","article-title":"Cell-penetrating peptides transport therapeutics into cells","volume":"154","author":"Ramsey","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104191","article-title":"Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery","volume":"29","author":"Maani","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ymthe.2026.08.025_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.34172\/apb.2024.045","article-title":"Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment","volume":"14","author":"Amiri Zadeh Fard","year":"2024","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ymthe.2026.08.025_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jcmgh.2023.11.012","article-title":"Vasoactive Intestinal Polypeptide Plays a Key Role in the Microbial-Neuroimmune Control of Intestinal Motility","volume":"17","author":"Bai","year":"2024","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/polym17091174","article-title":"Polymer Micelles as Nanocarriers of Bioactive Peptides","volume":"17","author":"Petrov","year":"2025","journal-title":"Polymers"},{"key":"10.1016\/j.ymthe.2026.08.025_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41433-023-02844-x","article-title":"Retinal VIP-amacrine cells: their development, structure, and function","volume":"38","author":"Zhang","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.ymthe.2026.08.025_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13357","article-title":"The role of hormones in ILC2-driven allergic airway inflammation","volume":"99","author":"Dai","year":"2024","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0008-2024","article-title":"Neuroimmune recognition and regulation in the respiratory system","volume":"33","author":"Chen","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.ymthe.2026.08.025_bib25","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biochi.2023.07.011","article-title":"Heme and Cu(2+)-induced vasoactive intestinal peptide (VIP) tyrosine nitration: A possible molecular mechanism for the attenuated anti-inflammatory effect of VIP in inflammatory diseases","volume":"214","author":"Zeng","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.ymthe.2026.08.025_bib26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2011-200100","article-title":"Molecular engineering of short half-life small peptides (VIP, \u03b1MSH and \u03b33MSH) fused to latency-associated peptide results in improved anti-inflammatory therapeutics","volume":"71","author":"Vessillier","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ymthe.2026.08.025_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217855","article-title":"Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis","volume":"628","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.08.025_bib28","doi-asserted-by":"crossref","first-page":"2054-68.e6","DOI":"10.1016\/j.immuni.2025.05.002","article-title":"Nociceptor neurons suppress alveolar macrophage-induced Siglec-F(+) neutrophil-mediated inflammation to protect against pulmonary fibrosis","volume":"58","author":"Hiroki","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.025_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202300250","article-title":"Delays Intervertebral Disc Degeneration via FGF18\/FGFR2-Mediated Activation of Akt Signaling Pathway","volume":"8","author":"Sun","year":"2024","journal-title":"Adv. Biol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41392-025-02494-3","article-title":"Beyond barriers: when neurons act immune and immunity acts neural","volume":"10","author":"Kim","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","article-title":"Engineering circular RNA for enhanced protein production","volume":"41","author":"Chen","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-025-01193-z","article-title":"Human coronavirus OC43 infection in human cerebral organoids: novel insights on pathogenesis and potential therapeutic interventions","volume":"32","author":"Liu","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ymthe.2026.08.025_bib33","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.025_bib34","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.025_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101505","article-title":"Membrane-modified lipid nanoparticles for RNA delivery","volume":"33","author":"Roy Chowdhury","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2026.08.025_bib36","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.1016\/j.cell.2025.07.022","article-title":"Mucosal viral infection elicits long-lived IgA responses via type 1 follicular helper T cells","volume":"188","author":"Haniuda","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.08.025_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41576-024-00806-x","article-title":"The therapeutic potential of circular RNAs","volume":"26","author":"O'Leary","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.08.025_bib38","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ymthe.2021.01.018","article-title":"Circular RNAs: Expression, localization, and therapeutic potentials","volume":"29","author":"Yang","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70056","article-title":"Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ymthe.2026.08.025_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.08.025_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.anai.2020.03.017","article-title":"The journey to a respiratory syncytial virus vaccine","volume":"125","author":"Mejias","year":"2020","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13020097","article-title":"Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines","volume":"13","author":"Anastassopoulou","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.08.025_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/v18010036","article-title":"Crucial Obstacles and Strategies for Human RSV Pediatric Vaccine Development","volume":"18","author":"Ling","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.08.025_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12090980","article-title":"Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates","volume":"12","author":"Papazisis","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.08.025_bib45","first-page":"592","article-title":"B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection","volume":"9","author":"Li","year":"2021","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41590-022-01253-8","article-title":"Targeting T(FH) cells in human diseases and vaccination: rationale and practice","volume":"23","author":"Yu","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib47","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.ymthe.2026.01.031","article-title":"Highly efficient and durable Th1-biased protective immunity from a novel mRNA vaccine against RSV via AI-assisted antigen screening","volume":"34","author":"Dong","year":"2026","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.08.025_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01302-17","article-title":"Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem","volume":"92","author":"Tripp","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2026.08.025_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105318","article-title":"The role of respiratory syncytial virus G protein in immune cell infection and pathogenesis","volume":"107","author":"Anderson","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymthe.2026.08.025_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8040558","article-title":"Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination","volume":"8","author":"Crofts","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.08.025_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1006\/viro.2002.1382","article-title":"RSV-induced immunopathology: dynamic interplay between the virus and host immune response","volume":"295","author":"Varga","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2026.08.025_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/v13122478","article-title":"Immunopathology of RSV: An Updated Review","volume":"13","author":"Bergeron","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.08.025_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122078","article-title":"Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge","volume":"10","author":"Powell","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ymthe.2026.08.025_bib54","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/s41467-025-56302-1","article-title":"A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus","volume":"16","author":"Lin","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.08.025_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2505718122","article-title":"Circular RNA lipid nanoparticle vaccine against SARS-CoV-2","volume":"122","author":"Swingle","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.08.025_bib56","first-page":"478","article-title":"RSV vaccination as the optimal prevention strategy for older adults","volume":"32","author":"Andreoni","year":"2024","journal-title":"Infez. Med."},{"key":"10.1016\/j.ymthe.2026.08.025_bib57","doi-asserted-by":"crossref","first-page":"e747","DOI":"10.1016\/S1473-3099(24)00455-9","article-title":"The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access","volume":"24","author":"Terstappen","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.08.025_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(24)00589-9","article-title":"Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial","volume":"25","author":"Goswami","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.08.025_bib59","doi-asserted-by":"crossref","first-page":"e647","DOI":"10.1093\/infdis\/jiae081","article-title":"Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults","volume":"230","author":"Shaw","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.08.025_bib60","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(22)00291-2","article-title":"Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape","volume":"23","author":"Mazur","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.08.025_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110184","article-title":"Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections","volume":"38","author":"Brandi","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2026.08.025_bib62","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/v17081025","article-title":"DNAJ Homolog Subfamily C Member 11 Stabilizes SARS-CoV-2 NSP3 to Promote Double-Membrane Vesicle Formation","volume":"17","author":"Chen","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ymthe.2026.08.025_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013593","article-title":"UBXN7 facilitates SARS-CoV-2 replication via inhibiting the K48-linked ubiquitination of viral N protein","volume":"21","author":"Xia","year":"2025","journal-title":"Plos Pathog."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626007069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:36:30Z","timestamp":1788262590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626007069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":63,"alternative-id":["S1525001626007069"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.025","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}